122 related articles for article (PubMed ID: 7776381)
1. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610.
Han H; Neubauer S; Braeker B; Ertl G
J Mol Cell Cardiol; 1995 Feb; 27(2):761-6. PubMed ID: 7776381
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model.
Szabó G; Fazekas L; Bährle S; MacDonald D; Stumpf N; Vahl CF; Hagl S
Cardiovasc Res; 1998 Sep; 39(3):683-90. PubMed ID: 9861312
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 increases susceptibility of isolated rat hearts to ischemia/reperfusion injury by reducing coronary flow.
de Groot MC; Illing B; Horn M; Urban B; Haase A; Schnackerz K; Neubauer S
J Mol Cell Cardiol; 1998 Dec; 30(12):2657-68. PubMed ID: 9990537
[TBL] [Abstract][Full Text] [Related]
5. Effects of endothelin-1 and the ETA-receptor antagonist, BQ123, on ischemic arrhythmias in anesthetized rats.
Garjani A; Wainwright CL; Zeitlin IJ; Wilson C; Slee SJ
J Cardiovasc Pharmacol; 1995 Apr; 25(4):634-42. PubMed ID: 7596133
[TBL] [Abstract][Full Text] [Related]
6. Endothelin does not contribute to the attenuation in myocardial function and blood flow after repetitive ischemia in the rat heart.
Tiefenbacher CP; Tweddell A; Batkai S; Zimmermann R; Tillmanns H; Kübler W
J Vasc Res; 1997; 34(6):447-54. PubMed ID: 9425997
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-A receptor antagonist BQ123 protects against myocardial and endothelial reperfusion injury.
Szabó G; Bährle S; Fazekas L; MacDonald D; Stumpf N; Vahl CF; Hagl S
Thorac Cardiovasc Surg; 1998 Aug; 46(4):232-6. PubMed ID: 9776499
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous endothelin peptides in intestinal ischemia-reperfusion injury in rats.
Anadol AZ; Bayram O; Dursun A; Ercan S
Prostaglandins Leukot Essent Fatty Acids; 1998 Oct; 59(4):279-83. PubMed ID: 9849655
[TBL] [Abstract][Full Text] [Related]
9. Endothelin release during ischaemia and reperfusion of isolated perfused rat hearts.
Brunner F; du Toit EF; Opie LH
J Mol Cell Cardiol; 1992 Nov; 24(11):1291-305. PubMed ID: 1479622
[TBL] [Abstract][Full Text] [Related]
10. Endothelin antagonists diminish postischemic microvascular incompetence and necrosis in the heart.
Maxwell L; Harrison WR; Gavin JB
Microvasc Res; 2000 Mar; 59(2):204-12. PubMed ID: 10684726
[TBL] [Abstract][Full Text] [Related]
11. Effects of an endothelin receptor antagonist TAK-044 on myocardial energy metabolism in ischemia/reperfused rat hearts.
Iimuro M; Kaneko M; Matsumoto Y; Fujise Y; Watanabe T; Hayashi H
J Cardiovasc Pharmacol; 2000 Mar; 35(3):403-9. PubMed ID: 10710125
[TBL] [Abstract][Full Text] [Related]
12. Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?
Sharif I; Kane KA; Wainwright CL
Cardiovasc Res; 1998 Sep; 39(3):625-32. PubMed ID: 9861305
[TBL] [Abstract][Full Text] [Related]
13. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
14. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload.
Ito H; Hiroe M; Hirata Y; Fujisaki H; Adachi S; Akimoto H; Ohta Y; Marumo F
Circulation; 1994 May; 89(5):2198-203. PubMed ID: 8181145
[TBL] [Abstract][Full Text] [Related]
15. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.
Hiramatsu T; Forbess J; Miura T; Roth SJ; Cioffi MA; Mayer JE
Circulation; 1995 Nov; 92(9 Suppl):II400-4. PubMed ID: 7586445
[TBL] [Abstract][Full Text] [Related]
16. Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts.
Cave AC; Horowitz GL; Apstein CS
J Mol Cell Cardiol; 1994 Nov; 26(11):1471-86. PubMed ID: 7897671
[TBL] [Abstract][Full Text] [Related]
17. Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart.
Galiñanes M; Bernocchi P; Argano V; Cargnoni A; Ferrari R; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):531-9. PubMed ID: 9011636
[TBL] [Abstract][Full Text] [Related]
18. Regulation of left ventricular relaxation in the isolated guinea-pig heart by endogenous endothelin.
Prendergast BD; Anning PB; Lewis MJ; Shah AM
Cardiovasc Res; 1997 Jan; 33(1):131-8. PubMed ID: 9059536
[TBL] [Abstract][Full Text] [Related]
19. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
McMurdo L; Thiemermann C; Vane JR
Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
[TBL] [Abstract][Full Text] [Related]
20. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
